GORAN ANDO - 03 Jan 2025 Form 4 Insider Report for EyePoint Pharmaceuticals, Inc. (EYPT)

Role
Director
Signature
/s/ Ron Honig, Attorney-in-Fact
Issuer symbol
EYPT
Transactions as of
03 Jan 2025
Net transactions value
$0
Form type
4
Filing time
07 Jan 2025, 16:04:52 UTC
Previous filing
21 Aug 2024
Next filing
06 Jan 2026
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EYPT Stock Option (Right to Buy) Award $0 +41,500 $0.000000 41,500 03 Jan 2025 Common Stock 41,500 $8.26 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.